glp-1 obesity drug news october 2025 today Outlook for obesity in 2025: more than a transition year Myths & Facts: GLP-1 Drugs
Description
51.4% of Patients Would Consider Using GLP-1 Drugs Again 51.4% of participants said they would use GLP-1s again
They help with weight loss but might cause side effects
Ozempic Ozempic works through the gut and brain
Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study
This work set out to discover how GLP-1 mitigates cholesterol-induced lipotoxicity in hepatocytes and what mechanisms are at play in this process
Biological and functional multimorbidityfrom mechanisms to management
